The chart below shows how CC performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CC sees a -0.12% change in stock price 10 days leading up to the earnings, and a -2.62% change 10 days following the report. On the earnings day itself, the stock moves by +1.57%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Record Net Sales Growth: TSS achieved record net sales of approximately $460 million, a 6% increase from the prior year, driven primarily by an 8% rise in volume.
Optoeon Refrigerants Sales Surge: The TSS business hit a robust 21% year-over-year increase in sales of Optoeon Refrigerants, reflecting nearly 60% of total TSS refrigerant sales for the quarter, up from 50% in the prior year.
Net Sales Increase: The company reported a consolidated net sales for the third quarter of approximately $1.5 billion, up 1% compared to the prior year quarter, driven by a 5% increase in volume.
Quarterly Savings Achievement: The company achieved incremental $30 million in savings during the quarter, bringing total savings to approximately $130 million in 2024, exceeding the targeted $125 million in year-over-year savings.
EBITDA Margin Improvement: Adjusted EBITDA margins improved to 13%, reflecting the company's continued focus on cost management and operational efficiency.
Negative
Net Loss Reported: Chemours reported a net loss of $27 million or $0.18 per diluted share compared to net income of $12 million or $0.08 per share in the prior year.
Net Loss Due to Impairment: The current quarter net loss includes a $56 million non-cash impairment charge.
Adjusted EBITDA Decline: Adjusted EBITDA decreased from $211 million last year to $208 million this quarter, attributed to lower pricing and currency fluctuations.
Net Sales Performance: The company’s consolidated net sales for the third quarter were approximately $1.5 billion, up only 1% compared to the prior year quarter, driven by a 5% increase in volume offset by a 3% decline in pricing.
EBITDA Margin Decline: The adjusted EBITDA margin fell to 13%, reflecting the impact of lower pricing and increased costs associated with securing near-term quota allowances.
The Chemours Company (CC) Q3 2024 Earnings Call Transcript
CC.N
1.28%